Ulcerative colitis‐associated neoplasia
2002; Wiley; Volume: 52; Issue: 3 Linguagem: Inglês
10.1046/j.1440-1827.2002.01333.x
ISSN1440-1827
AutoresShigehiko Fujii, Takahiro Fujimori, Hiroshi Kashida,
Tópico(s)Colorectal Cancer Screening and Detection
ResumoPathology InternationalVolume 52, Issue 3 p. 195-203 Ulcerative colitis-associated neoplasia Shigehiko Fujii, Shigehiko Fujii Department of Surgical and Molecular Pathology, Dokkyo University School of Medicine, Tochigi, JapanSearch for more papers by this authorTakahiro Fujimori, Takahiro Fujimori Department of Surgical and Molecular Pathology, Dokkyo University School of Medicine, Tochigi, JapanSearch for more papers by this authorHiroshi Kashida, Hiroshi Kashida Department of Surgical and Molecular Pathology, Dokkyo University School of Medicine, Tochigi, JapanSearch for more papers by this author Shigehiko Fujii, Shigehiko Fujii Department of Surgical and Molecular Pathology, Dokkyo University School of Medicine, Tochigi, JapanSearch for more papers by this authorTakahiro Fujimori, Takahiro Fujimori Department of Surgical and Molecular Pathology, Dokkyo University School of Medicine, Tochigi, JapanSearch for more papers by this authorHiroshi Kashida, Hiroshi Kashida Department of Surgical and Molecular Pathology, Dokkyo University School of Medicine, Tochigi, JapanSearch for more papers by this author First published: 09 May 2002 https://doi.org/10.1046/j.1440-1827.2002.01333.xCitations: 10 Takahiro Fujimori, MD, PhD, Department of Surgical and Molecular Pathology, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Shimotsuga, Tochigi 321-0293, Japan. Email: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Crohn BB, Rosenberg H. The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am. J. Med. Sci. 1925; 170: 220–228. 10.1097/00000441-192508010-00006 Web of Science®Google Scholar 2 Dobbins WO III. Dysplasia and malignancy in inflammatory bowel disease. Ann. Rev. Med. 1984; 35: 33–48. 10.1146/annurev.me.35.020184.000341 PubMedWeb of Science®Google Scholar 3 Levin B. Gastrointestinal neoplasia in inflammatory bowel disease. In: Kirsner JB, Shorter RG, eds. Inflammatory Bowel Disease, 4th edn. Baltimore: Williams and Wilkins, 1995; 461–473. Google Scholar 4 Greenstein AJ, Sachar DB, Smith H et al. Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 1979; 77: 290–294. 10.1016/0016-5085(79)90279-8 CASPubMedWeb of Science®Google Scholar 5 Nugent FW, Haggitt RC, Colcher H, Kutteruf GC. Malignant potential of chronic ulcerative colitis: preliminary report. Gastroenterology 1979; 76: 1–5. 10.1016/S0016-5085(79)80119-5 CASPubMedWeb of Science®Google Scholar 6 Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Part IV. Carcinoma of the colon. Gut 1964; 5: 15–22. 10.1136/gut.5.1.1 PubMedWeb of Science®Google Scholar 7 Ritchie JK, Hawley PR, Lennard-Jones JE. Prognosis of carcinoma in ulcerative colitis. Gut 1981; 22: 752–755. 10.1136/gut.22.9.752 PubMedWeb of Science®Google Scholar 8 Gyde SN, Prior P, Thompson H, Waterhouse JAH, Allan RN. Survival of patients with colorectal cancer complicating ulcerative colitis. Gut 1984; 25: 228–231. 10.1136/gut.25.3.228 CASPubMedWeb of Science®Google Scholar 9 Warren S, Sommers SC. Pathogenesis of ulcerative colitis. Am. J. Pathol. 1949; 25: 657–679. CASPubMedWeb of Science®Google Scholar 10 Morson BC, Pang LSC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967; 8: 423–434. 10.1136/gut.8.5.423 CASPubMedWeb of Science®Google Scholar 11 Blackstone MO, Riddel RH, Rogers BHG, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in longstanding ulcerative colitis: an indication for colectomy. Gastroenterology 1981; 80: 366–374. PubMedWeb of Science®Google Scholar 12 Riddel RH, Goldman H, Ransohoff DF et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum. Pathol. 1983; 14: 931–968. 10.1016/S0046-8177(83)80175-0 PubMedWeb of Science®Google Scholar 13 Konishi F, Wakasa H, Kino I, Watanabe H, Nagura H, Muto T. Histological Classification of the Neoplastic Epithelium Arising in Ulcerative Colitis. Annual Report (for 1992) of the Research Committee of Inflammatory Bowel Disease. Tokyo: Ministry of Health and Welfare of Japan, 1993; 153–156 (in Japanese with English abstract). Google Scholar 14 Rubin PH, Friedman S, Harpaz N et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 1999; 117: 1295–1300. 10.1016/S0016-5085(99)70279-9 CASPubMedWeb of Science®Google Scholar 15 Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 1999; 117: 1288–1294. 10.1016/S0016-5085(99)70278-7 CASPubMedWeb of Science®Google Scholar 16 Fujimori T, Miura M, Tonariya Y, TomitaT, Nagasako K. Ulcerative colitis complicated with two colonic carcinomas and precarcinomatous lesions, an autopsy case. Stom. Intest. 1980; 15: 323–330 (in Japanese with English abstract). Google Scholar 17 Nagasako K, Lizuka B, Ishii F, Miyazaki J, Fujimori T. Colonoscopic diagnosis of dysplasia and early cancer in longstanding colitis. J. Gastroenterol. 1995; 30: 36–39. PubMedWeb of Science®Google Scholar 18 Rozen P, Baratz M, Fefer F, Gilat T. Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 1995; 108: 1361–1370. 10.1016/0016-5085(95)90683-5 CASPubMedWeb of Science®Google Scholar 19 Lindberg B, Persson B, Veress B, Ingelman-Sundberg H, Granqvist S. Twenty years' colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation. Scand. J. Gastroenterol. 1963; 1: 1195–1204. Google Scholar 20 Lashner BA. Recommendations for colorectal cancer screening in ulcerative colitis: a review of research from a single University-based surveillance program. Am. J. Gastroenterol. 1992; 87: 168–175. CASPubMedWeb of Science®Google Scholar 21 Suzuki K, Muto T, Shinozaki M, Higuchi Y, Sawada T, Saito Y. Results of cancer surveillance in ulcerative colitis. J. Gastroenterol. 1995; 30: 40–42. PubMedWeb of Science®Google Scholar 22 Karlen P, Kornfeld D, Broström O, Löfberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 1998; 42: 711–714. 10.1136/gut.42.5.711 CASPubMedWeb of Science®Google Scholar 23 Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB. Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990; 31: 800–806. 10.1136/gut.31.7.800 CASPubMedWeb of Science®Google Scholar 24 Nugent FW, Haggitt RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991; 100: 1241–1248. 10.1016/0016-5085(91)70010-U CASPubMedWeb of Science®Google Scholar 25 Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993; 105: 418–424. 10.1016/0016-5085(93)90715-O CASPubMedWeb of Science®Google Scholar 26 Taylor BA, Pemberton JH, Carpenter HA et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis. Colon Rectum 1992; 35: 950–956. 10.1007/BF02253497 CASPubMedWeb of Science®Google Scholar 27 Axon ATR. Surveillance in ulcerative colitis does not work and cannot work. In: Riddell RH, ed. Dysplasia and Cancer in Colitis. New York: Elsevier, 1991; 43–48. Google Scholar 28 Axon ATR. Cancer surveillance in ulcerative colitis – a time for reappraisal. Gut 1994; 35: 587–589. 10.1136/gut.35.5.587 PubMedWeb of Science®Google Scholar 29 Tada M, Kawai K, Niki H, Hattori T, Fujita S. Magnified observation of minute changes of polypoid lesions in the large intestine. Stom. Intest. 1978; 13: 625–636 (in Japanese with English abstract). Google Scholar 30 Igarashi M, Ooida M, Atari H et al. Magnifying endoscopic and histopathological findings of the various polypoid lesions in the large intestine. Gastroenterol. Endosc. 1981; 23: 540–550 (in Japanese with English abstract). Google Scholar 31 Kudo S, Miura K, Takano Y, Bannai H. Detection of colorectal minute cancer. Stom. Intest. 1990; 25: 801–812 (in Japanese with English abstract). Google Scholar 32 Fujimori T, Kashiwagi R, Nishitani K et al. Comparison of dissecting microscope findings between gastric and colorectal flat type differentiated adenocarcinoma. Endoscopia Digestiva 1995; 7: 241–250 (in Japanese with English abstract). Google Scholar 33 Hamilton SR, Vogelstein B, Kudo S et al. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. Lyon: IARC Press, 2000; 105–119. Web of Science®Google Scholar 34 Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N. Eng. J. Med. 1988; 319: 525–532. 10.1056/NEJM198809013190901 CASPubMedWeb of Science®Google Scholar 35 Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816–819. 10.1126/science.8484122 CASPubMedWeb of Science®Google Scholar 36 Inovo Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequence reveal a new mechanism for colonic carcinogenesis. Nature 1993; 365: 558–561. 10.1038/363558a0 Web of Science®Google Scholar 37 Leppert M, Dobbs M, Scambler P et al. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987; 238: 1411–1413. 10.1126/science.3479843 CASPubMedWeb of Science®Google Scholar 38 Bodmer WF, Bailey CJ, Bodmer J et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328: 614–616. 10.1038/328614a0 CASPubMedWeb of Science®Google Scholar 39 Kinzler KW, Nilbert MC, Su LK et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661–665. 10.1126/science.1651562 CASPubMedWeb of Science®Google Scholar 40 Groden J, Thliveris A, Samowitz W et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589–600. 10.1016/0092-8674(81)90021-0 CASPubMedWeb of Science®Google Scholar 41 Powell SM, Zilz N, Beazer-Barclay Y et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359: 235–237. 10.1038/359235a0 CASPubMedWeb of Science®Google Scholar 42 Greenwald BD, Harpaz N, Yin J et al. Loss of heterozygosity affecting the p53, Rb, and mcc/APC tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res. 1992; 52: 741–745. CASPubMedWeb of Science®Google Scholar 43 Kern SE, Redston M, Caldas C et al. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 1994; 107: 420–428. 10.1016/0016-5085(94)90167-8 CASPubMedWeb of Science®Google Scholar 44 Tarmin L, Yin J, Harpaz N et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasia and cancers versus sporadic colon neoplasms. Cancer Res. 1995; 55: 2035–2038. CASPubMedWeb of Science®Google Scholar 45 Umetani N, Sasaki S, Watanabe T et al. Genetic alterations in ulcerative colitis-associated neoplasia focusing on APC, K-ras gene and microsatellite instability. Jpn. J. Cancer Res. 1999; 90: 1081–1087. 10.1111/j.1349-7006.1999.tb00681.x CASPubMedWeb of Science®Google Scholar 46 Fujimori T, Satonaka K, Yamamura-Idei Y, Nagasako K, Maeda S. Non-involvement of ras mutations on flat colorectal adenomas and carcinomas. Int. J. Cancer 1994; 57: 51–55. 10.1002/ijc.2910570110 CASPubMedWeb of Science®Google Scholar 47 Fujimori T, Ono Y, Sakuma K, Ueda Y, Terano A. Genetic changes in colorectal adenoma and carcinoma in relation to various morphologic aspects. J. Gastroenterol. 1998; 33: 804–810.DOI: 10.1007/s005350050179 10.1007/s005350050179 CASPubMedWeb of Science®Google Scholar 48 Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS. c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 1990; 99: 416–420. 10.1016/0016-5085(90)91024-Z CASPubMedWeb of Science®Google Scholar 49 Bell SM, Kelly SA, Hoyle JA et al. c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br. J. Cancer 1991; 64: 174–178. 10.1038/bjc.1991.264 CASPubMedWeb of Science®Google Scholar 50 Chen J, Compton C, Cheng E, Fromowitz F, Viola MV. c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis. Gastroenterology 1992; 102: 1983–1987. 10.1016/0016-5085(92)90323-Q PubMedWeb of Science®Google Scholar 51 Chaubert P, Benhattar J, Saraga E, Costa J. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am. J. Pathol. 1994; 144: 767–775. CASPubMedWeb of Science®Google Scholar 52 Holzmann K, Klump B, Borchard F et al. Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. Int. J. Cancer 1998; 76: 1–6.DOI: 10.1002/(sici)1097-0215(19980330)76:1 3.0.co;2-4 10.1002/(sici)1097-0215(19980330)76:1 3.0.co;2-4 CASPubMedGoogle Scholar 53 Brachmann RK, Vidal M, Boeke JD. Dominant-negative p53 mutations selected in yeast hit cancer hot spots. Proc. Natl Acad. Sci. USA 1996; 93: 4091–4095. 10.1073/pnas.93.9.4091 CASPubMedWeb of Science®Google Scholar 54 Baker SJ, Preisinger AC, Jessup JM et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 1990; 50: 7717–7722. CASPubMedWeb of Science®Google Scholar 55 Yin J, Harpez N, Tong Y et al. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 1993; 104: 1633–1639. 10.1016/0016-5085(93)90639-T CASPubMedWeb of Science®Google Scholar 56 Harpaz N, Peck AL, Yin J et al. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum. Pathol. 1994; 25: 1069–1074. 10.1016/0046-8177(94)90067-1 PubMedWeb of Science®Google Scholar 57 Brentnall TA, Crispin DA, Rabinovitsch PS et al. Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994; 107: 369–378. 10.1016/0016-5085(94)90161-9 CASPubMedWeb of Science®Google Scholar 58 Toda J, Nagasako K, Fujimori T, Kato Y, Hayashi N. The study of genetic changes in colorectal cancer with ulcerative colitis. Nippon Shokakibyo Gakkai Zasshi 1998; 95: 123–132 (in Japanese with English abstract). CASPubMedGoogle Scholar 59 Walsh SV, Loda M, Torres CM, Antonioli D, Odze RD. p53 and β-catenin expression in chronic ulcerative colitis–associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Am. J. Surg. Pathol. 1999; 23: 963–969. 10.1097/00000478-199908000-00015 CASPubMedWeb of Science®Google Scholar 60 Eppert K, Scherer SW, Ozcelik H et al. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996; 86: 543–552. 10.1016/S0092-8674(00)80128-2 CASPubMedWeb of Science®Google Scholar 61 Riggins GJ, Thiagalingam S, Rozenblum E et al. Mad-related genes in the human. Nat. Genet. 1996; 13: 347–349. 10.1038/ng0796-347 CASPubMedWeb of Science®Google Scholar 62 Willenbucher RF, Aust DE, Chang CG et al. Genomic instability is an early event during the progression pathway of ulcerative colitis-related neoplasia. Am. J. Pathol. 1999; 154: 1825–1830. 10.1016/S0002-9440(10)65438-7 CASPubMedWeb of Science®Google Scholar 63 Suzuki H, Harpaz N, Tarmin L et al. Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers. Cancer Res. 1994; 54: 4841–4844. CASPubMedWeb of Science®Google Scholar 64 Brentnall TA, Crispin DA, Bronner MP et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res. 1996; 56: 1237–1240. CASPubMedWeb of Science®Google Scholar 65 Cawkwell L, Sutherland F, Murgatroyd H et al. Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis-associated colorectal cancers. Gut 2000; 46: 367–369. 10.1136/gut.46.3.367 CASPubMedWeb of Science®Google Scholar 66 Boland CR, Thibodeau SN, Hamilton SR et al. National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998; 58: 5248–5257. CASPubMedWeb of Science®Google Scholar 67 Herman JG, Merlo A, Mao L et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995; 55: 4525–4530. CASPubMedWeb of Science®Google Scholar 68 Cairns P, Polascik TJ, Eby Y et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet. 1995; 11: 210–212. 10.1038/ng1095-210 CASPubMedWeb of Science®Google Scholar 69 Ohhara M, Esumi M, Kurosu Y. Activation but not inactivation of the MTS1 gene is associated with primary colorectal carcinomas. Biochem. Biophys. Res. Commun. 1996; 226: 791–795. 10.1006/bbrc.1996.1430 CASPubMedWeb of Science®Google Scholar 70 Gonzalez-Zulueta M, Bender CM, Yang AS et al. Methylation of the 5′-CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 1995; 55: 4531–4535. CASPubMedWeb of Science®Google Scholar 71 Hsieh CJ, Klump B, Holzmann K, Borchard F, Gregor M, Porschen R. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res. 1998; 58: 3942–3945. CASPubMedWeb of Science®Google Scholar 72 Greenstein AJ, Gennuso R, Sachar DB et al. Extraintestinal cancers in inflammatory bowel disease. Cancer 1985; 56: 2914–2921. 10.1002/1097-0142(19851215)56:12 3.0.CO;2-J CASPubMedWeb of Science®Google Scholar 73 Baker D, Chiprut RO, Rimer D, Lewin KJ, Rosenberg MZ. Colonic lymphoma in ulcerative colitis. J. Clin. Gastroenterol. 1985; 7: 379–386. 10.1097/00004836-198510000-00002 CASPubMedWeb of Science®Google Scholar 74 Shepherd NA, Hall PA, Williams GT et al. Primary malignant lymphoma of the large intestine complicating chronic inflammatory bowel disease. Histopathology 1989; 15: 325–337. 10.1111/j.1365-2559.1989.tb01585.x CASPubMedWeb of Science®Google Scholar 75 Greenstein AJ, Mullin GE, Strauchen JA et al. Lymphoma in inflammatory bowel disease. Cancer 1992; 69: 1119–1123. 10.1002/cncr.2820690510 CASPubMedWeb of Science®Google Scholar 76 Dodd SM. Chronic ulcerative colitis complicated by atypical carcinoid tumor. J. Clin. Pathol. 1986; 39: 913–916. 10.1136/jcp.39.8.913 CASPubMedWeb of Science®Google Scholar 77 Farr CM, Rajala WP. Carcinoid tumor complicating ulcerative colitis. Gastrointest. Endosc. 1990; 36: 315–316. 10.1016/S0016-5107(90)71038-3 CASPubMedWeb of Science®Google Scholar 78 McNeely B, Owen DA, Pezim M. Multiple microcarcinoids arising in chronic ulcerative colitis. Am. J. Clin. Pathol. 1992; 98: 112–116. 10.1093/ajcp/98.1.112 PubMedWeb of Science®Google Scholar 79 Gledhill A, Hall PA, Cruse JP, Pollock DJ. Enteroendocrine cell hyperplasia, carcinoid tumors and adenocarcinoma in long-standing ulcerative colitis. Histopathology 1986; 10: 501–508. 10.1111/j.1365-2559.1986.tb02501.x CASPubMedWeb of Science®Google Scholar 80 Gordon HW, Rywlin AM. Kaposi's sarcoma of the large intestine associated with ulcerative colitis. Gastroenterology 1966; 50: 248–253. Web of Science®Google Scholar 81 Converse CF, Reagan JW, DeCosse JJ. Ulcerative colitis and carcinoma of the bile ducts. Am. J. Surg. 1971; 121: 39–45. 10.1016/0002-9610(71)90075-4 PubMedWeb of Science®Google Scholar 82 Ritchie JK, Allan RN, MacArtney J, Thompson H, Hawley PR, Cooke WT. Biliary tract carcinoma associated with ulcerative colitis. Am. J. Med. 1974; 43: 263–279. CASPubMedWeb of Science®Google Scholar Citing Literature Volume52, Issue3March 2002Pages 195-203 ReferencesRelatedInformation
Referência(s)